Hyperparathyroidism, Secondary: all 190 studies
Page 1 of 2. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.
- A Study of PLS240 in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisNot yet recruitingNCT07890584Phase 3
- Hyperparathyroidism and Dialysis Adequacy in Hemodialysis PatientsNot yet recruitingNCT07820150
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric ParticipantsRecruitingNCT07494045Phase 2
- Study of MT1013 for the Treatment of Patients With Secondary HyperparathyroidismRecruitingNCT07122401Phase 3
- Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance DialysisRecruitingNCT06976177Phase 2
- Thermal Ablation Versus Parathyroidectomy for Secondary HyperparathyroidismNot yet recruitingNCT06709586
- Intraoperative Parathyroid Hormone Monitoring to Guide Surgery in Renal hyperparathyroIdismNot yet recruitingNCT06542315Not applicable
- The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKDNot yet recruitingNCT06398002Phase 2
- Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal FailureNot yet recruitingNCT06378931
- A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.RecruitingNCT06126016
- Parathyroid Tumor Clonal StatusRecruitingNCT05997810
- Precision Medicine Approaches to Renal OsteodystrophyRecruitingNCT05880914
- Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary HyperparathyroidismRecruitingNCT04922892Not applicable
- A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving HemodialysisRecruitingNCT03969329Phase 3
- A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisRecruitingNCT03633708Phase 3
- Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary HyperparathyroidismTerminatedNCT05543928Phase 3Results posted
- A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)TerminatedNCT04064827Phase 3Results posted
- The Effect of Etelcalcetide on CKD-MBDCompletedNCT03960437Phase 2Results posted
- Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)CompletedNCT03299244Phase 3Results posted
- A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416CompletedNCT03283098Phase 1Results posted
- A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving HaemodialysisCompletedNCT02833857Phase 1Results posted
- Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on DialysisCompletedNCT02341417Phase 3Results posted
- Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002CompletedNCT02282813Phase 3Results posted
- Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on DialysisTerminatedNCT02138838Phase 3Results posted
- Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT02102204Phase 3Results posted
- Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving DialysisCompletedNCT02054572Phase 1Results posted
- Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.CompletedNCT01939977Phase 4Results posted
- Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to EtelcalcetideCompletedNCT01932970Phase 3Results posted
- Head-to-Head Study of Etelcalcetide (AMG 416) and CinacalcetCompletedNCT01896232Phase 3Results posted
- Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on HemodialysisCompletedNCT01788046Phase 3Results posted
- Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on HemodialysisCompletedNCT01785875Phase 3Results posted
- Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT01785849Phase 3Results posted
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. ParicalcitolTerminatedNCT01725113Phase 4Results posted
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedNCT01704079Phase 3Results posted
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedNCT01651000Phase 3Results posted
- Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary HyperparathyroidismTerminatedNCT01576146Phase 2Results posted
- A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant PatientsCompletedNCT01506947Phase 4Results posted
- Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary HyperparathyroidismTerminatedNCT01439867Phase 2Results posted
- Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone DisorderCompletedNCT01414114Phase 2Results posted
- Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian FederationCompletedNCT01401478Results posted
- A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or HemodialysisCompletedNCT01382212Phase 3Results posted
- Quality of Life in Greek Hemodialysis Patients Receiving Zemplar IntravenousCompletedNCT01368042Results posted
- Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary HyperparathyroidismCompletedNCT01341782Phase 3Results posted
- Study to Evaluate Cinacalcet in Children With Chronic Kidney DiseaseCompletedNCT01290029Phase 1Results posted
- Pediatric Chronic Kidney Disease Safety and EfficacyTerminatedNCT01277510Phase 3Results posted
- Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on DialysisCompletedNCT01265992Results posted
- Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary HyperparathyroidismCompletedNCT01254565Phase 2Results posted
- Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)CompletedNCT01224782Results posted
- Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)CompletedNCT01219855Phase 2/3Results posted
- Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney DiseaseCompletedNCT01191762Phase 3Results posted
- Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing HemodialysisCompletedNCT01181531Phase 4Results posted
- Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass SurgeryCompletedNCT01138475Phase 3Results posted
- Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary HyperparathyroidismCompletedNCT01134562Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male VolunteersCompletedNCT01134549Phase 1Results posted
- Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical PracticeTerminatedNCT01134315Results posted
- Trial to Optimize Mineral Outcomes in Dialysis PatientsCompletedNCT01100723Phase 4Results posted
- Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical PracticeCompletedNCT01083849Results posted
- Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek ExperienceCompletedNCT01083186Results posted
- Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary HyperparathyroidismCompletedNCT01081665Results posted
- Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 YearsCompletedNCT01073462Results posted
- Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney DiseaseTerminatedNCT01012414Phase 3Results posted
- FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney DiseaseCompletedNCT00999037Not applicableResults posted
- Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary HyperparathyroidismCompletedNCT00990704Phase 2Results posted
- Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin DCompletedNCT00977080Phase 4Results posted
- Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial DoseCompletedNCT00891813Phase 4Results posted
- Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)CompletedNCT00828347Not applicableResults posted
- Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)CompletedNCT00823303Phase 4Results posted
- 20070360 Incident DialysisCompletedNCT00803712Phase 4Results posted
- Suspected Deficient Activation of Vitamin D in Patients With Secondary HyperparathyroidismCompletedNCT00754442Not applicableResults posted
- Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)CompletedNCT00701805Phase 2Results posted
- Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving HemodialysisCompletedNCT00667576Phase 2Results posted
- Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis SubjectsTerminatedNCT00664430Phase 4Results posted
- Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant PatientsTerminatedNCT00646282Phase 4Results posted
- Oral Paricalcitol in Kidney Transplant RecipientsCompletedNCT00587158Not applicableResults posted
- Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on DialysisCompletedNCT00537979Phase 4Results posted
- How Vitamin D Analogues Affect Endothelial Cells in Patients on DialysisCompletedNCT00528788Phase 4Results posted
- A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)CompletedNCT00431496Phase 4Results posted
- Cinacalcet to Treat Hypercalcemia in Renal Transplant RecipientsTerminatedNCT00415584Phase 1/2Results posted
- ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving HemodialysisCompletedNCT00379899Phase 4Results posted
- E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular EventsCompletedNCT00345839Phase 3Results posted
- Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney DiseaseCompletedNCT00285467Not applicableResults posted
- Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal DiseaseCompletedNCT00261950Phase 2Results posted
- A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney DiseaseCompletedNCT00257920Phase 4Results posted
- Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency PatientsCompletedNCT00042432Phase 2Results posted
- Cardiovascular Mortality Prediction in Maintenance Hemodialysis PatientsCompletedNCT07769190
- A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary HyperparathyroidismCompletedNCT06877247Phase 1
- A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary HyperparathyroidismCompletedNCT06747247Phase 2
- MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney DiseaseCompletedNCT06690242Phase 2
- The Trial of SHR6508 in Secondary HyperparathyroidismCompletedNCT06434961Phase 3
- Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical TrialCompletedNCT06236295Phase 2
- Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary HyperparathyroidismCompletedNCT06187480
- Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary HyperparathyroidismActive, not recruitingNCT06130683
- Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2CompletedNCT05836220Phase 3
- Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1CompletedNCT05832931Phase 3
- A Study of SHR6508 in Secondary HyperparathyroidismStatus unknownNCT05663411Phase 2
- A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D SupplementationStatus unknownNCT05549154Not applicable
- Diagnostic Accuracy of 3T MR for Secondary Hyperparathyroidism Comparison With 4DCTCompletedNCT05540795
- Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After ParathyroidectomyCompletedNCT05382988Phase 3
- Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its TreatmentCompletedNCT05347082Not applicable
- A Trial of SHR6508 in Secondary HyperparathyroidismCompletedNCT05221008Phase 1